Citi Initiates Coverage on Alnylam Pharmaceuticals with Buy Rating GitHub Outages and Competitive Pressure Challenge Microsofts AI Coding Dominance Nvidia Earnings Call May Test US Equities Amid China Chip and Trade Policy Speculation Trump Asks Supreme Court to Pause TikTok BanLegal Battle Intensifies Amgen Releases Q1 2026 Earnings Highlights The Fed May Have Fewer Justifications for Rate Cuts CNBC Analysis Suggests CRS Q1 2026 Earnings EPS Exceeds Expectations Amid Cautious Market Response Quoin Pharmaceuticals Ltd Q1 2026 Earnings NarrowerThanExpected Loss Amid PreRevenue Phase WES Q1 2026 Earnings Strong EPS Beat Drives Positive Momentum Despite Slight Stock Pullback Nextpower Inc NXT Q1 2026 Earnings EPS Beats Estimates by 1316 Stock Jumps 78 Aurora Innovation Q1 2026 Earnings EPS Beat Masks PreRevenue Reality Amid Ongoing Development Costs Fate Therapeutics Q1 2026 Earnings EPS Beat Drives Stock Uptick Amid Continued Pipeline Progress StoneBridge Acquisition II Corporation Units APACU Holds Steady at 1020 With No Net Change Blackrock Enhanced International Dividend Trust BGY Edges Lower as Yield Focus Persists Oppenheimer Holdings OPY Holds Steady Near 94 as Trading Volume Signals Caution Agriculture Natural Solutions Acquisition Corporation ANSC Holds Steady at 1136 Trading Within Established Range FirstService Corporation FSV Holds Steady Near Support as Sector Headwinds Persist Electric Boats Submarine Manufacturing Drives Connecticut Jobs Revival Mannatech MTEX Q3 2023 Earnings Slim Profit Amid Quiet Market Reaction Social Commerce Partners Corporation Warrant SCPQW Rallies 13 Amid Renewed Interest